AMRYT PHARMA PLC's ticker is AMYT and the CUSIP is 03217L106. A total of 65 filers reported holding AMRYT PHARMA PLC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $15,322,649 | +10.8% | 2,098,993 | +5.0% | 5.76% | +15.4% |
| Q3 2022 | $13,833,000 | +6.0% | 1,998,993 | +7.1% | 4.99% | +12.0% |
| Q2 2022 | $13,048,000 | -3.8% | 1,866,652 | +13.8% | 4.45% | +123.4% |
| Q1 2022 | $13,563,000 | -23.4% | 1,640,000 | 0.0% | 1.99% | -0.8% |
| Q4 2021 | $17,712,000 | +5.8% | 1,640,000 | +18.0% | 2.01% | -33.9% |
| Q3 2021 | $16,743,000 | +21.1% | 1,390,000 | +21.9% | 3.04% | -15.4% |
| Q2 2021 | $13,828,000 | +24.1% | 1,140,000 | +42.5% | 3.59% | +78.4% |
| Q1 2021 | $11,144,000 | -1.6% | 800,000 | 0.0% | 2.01% | -14.4% |
| Q4 2020 | $11,328,000 | – | 800,000 | – | 2.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 8,857,268 | $61,912,000 | 26.04% |
| Stonepine Capital Management, LLC | 6,298,348 | $44,025,000 | 20.48% |
| MPM ASSET MANAGEMENT LLC | 2,668,843 | $18,655,000 | 7.87% |
| Aquilo Capital Management, LLC | 1,866,652 | $13,048,000 | 4.45% |
| New Leaf Venture Partners, L.L.C. | 449,737 | $3,144,000 | 2.04% |
| Global Frontier Investments LLC | 435,000 | $3,040,000 | 1.42% |
| Rubric Capital Management LP | 3,600,000 | $25,164,000 | 1.32% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 6,333,552 | $44,272,000 | 1.01% |
| Telemetry Investments, L.L.C. | 121,670 | $850,000 | 1.01% |
| Clearline Capital LP | 631,942 | $4,417,000 | 0.57% |